Company / Return on Assets (ROA)
Ligand Pharmaceuticals, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
8.0%
FY2025
5-year range
-4.4% / 8.0%
FY2021-FY2025
Trend
+1953.5%
vs FY2024
Sector context
#31 of 213
Health Care
What the data says
Return on Assets (ROA) changed +1953% YoY in FY2025, a notable deviation from the 9-year average annual change of +608%.
Based on SEC 10-K filings.
8.0% in FY2025 with a 5-year CAGR of +8.2%. Top quartile in the Health Care sector.
Improved from 6.6% to 8.0% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +12.3pp
- 5-Year Change
- +8.2pp
- 10-Year Change
- -
Sector benchmark
Top 15% in Health CareTop 15% of 213This company 8.0% Sector average -24.1%
▼
+133.0% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 1953.5% year-over-year.
- Currently 32.1pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2019.
- Lowest return on assets (roa) in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 8.0% | +1953.5% |
| FY2024 | -0.4% | -106.5% |
| FY2023 | 6.6% | +251.7% |
| FY2022 | -4.4% | -199.3% |
| FY2021 | 4.4% | +2100.0% |
| FY2020 | -0.2% | -100.5% |
| FY2019 | 42.1% | +270.3% |
| FY2018 | 11.4% | +508.0% |
| FY2017 | 1.9% | +792.6% |
| FY2016 | -0.3% | -100.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026